Secondary Impact of the COVID-19 Pandemic on Patients With Heart Failure
2020; Lippincott Williams & Wilkins; Volume: 13; Issue: 5 Linguagem: Inglês
10.1161/circheartfailure.120.007219
ISSN1941-3297
AutoresNosheen Reza, Ersilia M. DeFilippis, Mariell Jessup,
Tópico(s)Cardiovascular Effects of Exercise
ResumoHomeCirculation: Heart FailureVol. 13, No. 5Secondary Impact of the COVID-19 Pandemic on Patients With Heart Failure Free AccessArticle CommentaryPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessArticle CommentaryPDF/EPUBSecondary Impact of the COVID-19 Pandemic on Patients With Heart Failure Nosheen Reza, Ersilia M. DeFilippis and Mariell Jessup Nosheen RezaNosheen Reza Correspondence to: Nosheen Reza, MD, Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, 11 S Tower, Room 11-134, 3400 Civic Center Blvd, Philadelphia, PA 19104. Email E-mail Address: [email protected] https://orcid.org/0000-0002-2942-3731 Division of Cardiology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (N.R.). , Ersilia M. DeFilippisErsilia M. DeFilippis Division of Cardiology, Columbia University Irving Medical Center, New York, NY (E.M.D.). and Mariell JessupMariell Jessup American Heart Association, Dallas, TX (M.J.). Originally published30 Apr 2020https://doi.org/10.1161/CIRCHEARTFAILURE.120.007219Circulation: Heart Failure. 2020;13:e007219The novel coronavirus disease 2019 (COVID-19) pandemic has presented 2 sets of challenges to the heart failure (HF) community. First, we were forced to rapidly establish best practices for the care of patients with HF and COVID-19 and to manage its cardiovascular complications. Although health systems have been immediately and appropriately focused on mitigation, we must prepare for the second wave of challenges ahead—the consequences of disruptions in HF care at the patient, provider, and systems levels.Patient LevelBy April 2020, an unprecedented 12 million Americans had filed for unemployment benefits.1 Poverty and unemployment, and their attendant consequences like loneliness and isolation, are associated with increased risks for cardiovascular mortality.2 We can anticipate that this economic upheaval will result in enormous numbers of patients with HF becoming underinsured and unable to afford life-sustaining and life-saving therapies. Preexisting health inequities are being magnified by COVID-19, and underrepresented minorities are suffering a disproportionate burden of devastation.3 During this time, the physical separation of patients from their caregiver teams may further exacerbate this socioeconomic deprivation. Changes in dietary and lifestyle behaviors during social isolation, like increased processed foods and alcohol consumption and decreased physical activity, may trigger HF destabilizations. Amplifying the messages that those with chronic conditions should practice social distancing and stay home may confuse and frighten patients with HF, leading them to delay evaluation for advanced congestive or low output symptoms and suffer worse outcomes. Alternatively, patients with progressive symptoms, either due to COVID-19 or underlying disease, may choose to stay home with family rather than risk dying isolated in the hospital.A multifaceted approach will be critical to overcome this crisis. Now, in-person and virtual remote care services are of high value. The capacity for and consolidation of home visits during which providers check vital signs and weights, perform blood draws, administer intravenous diuretics, and deliver prescriptions should be rapidly scaled. Patients should be proactively enrolled in telehealth programs and equipped with physiological monitors that can communicate information to providers. Clinicians should incorporate targeted questioning regarding changes in food stability, alcohol use, psychological health, physical activity, and caregiver support status into their assessments and should regularly reinforce the indications for seeking medical evaluation. Palliative care and hospice services need to be expanded in parallel. Unfortunately, socioeconomically disadvantaged populations are less likely to have access to, and, therefore, benefit from, this intensification of remote care, and may endure disproportionate cardiovascular morbidity and mortality. Effective alternative outreach initiatives for these populations are urgently needed (Figure).Download figureDownload PowerPointFigure. Mitigation strategies, consequences, ongoing adaptations to, and anticipated impacts of disruptions in heart failure care delivery imposed by the coronavirus disease 2019 (COVID-19) pandemic. CRT indicates cardiac resynchronization therapy; GDMT, guideline-directed medical therapy; HF, heart failure; HT, heart transplantation; ICD, implantable cardioverter-defibrillator; ICU, intensive care unit; SDOH, social determinants of health; STEMI, ST-elevation myocardial infarction; and VAD, ventricular assist device.Provider LevelDistancing imperatives and telemedicine have transformed ambulatory HF care. We now assess disease progression without routine diagnostics, such as physical exams, echocardiograms, cardiopulmonary exercise testing, and right heart catheterizations. Titration of guideline-directed medical therapy for HF with reduced ejection fraction is being hampered as laboratory services, and nonessential contact are restricted. Clinicians may have to preferentially dose adjust β-blockers as the recommended monitoring for the titration of other guideline-directed medical therapy is less accessible. Paradoxically, individuals who may gain considerable benefit from optimal guideline-directed medical therapy, for example, the elderly and those with chronic kidney disease, may be those who are more likely to have titration delayed out of concern for needing more frequent blood draws. In contemporary practice, a majority of patients are not being treated with target guideline-directed medical therapy doses, and the barriers imposed by COVID-19 will further delay realization of this goal.Similarly, stable patients with HF with reduced ejection fraction will have primary prevention implantable cardioverter-defibrillator implantations and cardiac resynchronization therapy deferred as elective procedures are differentially prioritized. With no foreseeable end to pandemic restrictions, the competing risks of delays in maximizing disease-modifying therapy and of sudden death should be balanced on an individual basis. Health system and national registry data collection will be essential to determine the impacts of these triage decisions.Evaluation of patients with advanced HF awaiting ventricular assist device placement and heart transplantation may also be interrupted, as traditional social work, nutrition, pharmacy referrals, and diagnostic procedures are delayed. Telemedicine offers a platform for these multidisciplinary assessments to occur serially or simultaneously. It also permits caregivers who would not have been able to attend an in-person evaluation to participate remotely (Figure).Systems LevelPreliminary data collected during the COVID-19 pandemic has shown reductions in US cardiac catheterization laboratory activations for ST-elevation myocardial infarction and increases in severity of presentations to care due to undiagnosed ST-elevation myocardial infarction complications.4 While robust data are lacking, clinicians suspect that patients are avoiding cardiovascular evaluation out of fear of contracting COVID-19 in medical settings. Incident HF may surge, and we may experience a biphasic demand for advanced HF services, including mechanical circulatory support and urgent heart transplantation evaluations, as patients with delayed ST-elevation myocardial infarction and malignant arrhythmia present in acute HF during this time period and with subacute HF in the coming weeks. Changes in organ availability and center-level practice variation may negatively impact waitlist mortality. The cascading consequences of these delays are likely to disproportionately impact our most disadvantaged populations.When in-person clinic visits and elective procedures resume, traditional ambulatory models may become overwhelmed. Prioritization schemes for evaluation and treatment will have to be implemented. Our care delivery systems must be agile and ready to accommodate these patients in all settings. As we relaunch prepandemic workflows, we may find that some of our prior paradigms were superfluous and distracting us from providing high quality and high-value HF care.At most institutions, clinical trials unrelated to COVID-19 have been paused. Trial enrollment and study interventions requiring in-person visitation and procedural resources have been suspended. Safety visits are being performed via telemedicine services. Our patients may suffer from suspension of or lack of access to interventions that may improve their quality of life, morbidity, and mortality. Moving forward, the results of these trials will have to be interpreted in the context of the pandemic as clinical event and adjudication definitions may need to be reconsidered before applying them to our HF population at large (Figure).5ConclusionsThe COVID-19 pandemic has challenged our health care systems in a myriad of ways. As we manage critically ill patients in emergency rooms and intensive care units, we must remain mindful of patients with established HF currently out of our collective sight, of the potential impacts of our current resource allocation strategies, and of how we can proactively adapt systems now to continue to provide quality care.DisclosuresNone.FootnotesFor Disclosures, see page 3.The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Correspondence to: Nosheen Reza, MD, Division of Cardiovascular Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, 11 S Tower, Room 11-134, 3400 Civic Center Blvd, Philadelphia, PA 19104. Email nosheen.reza@pennmedicine.upenn.eduReferences1. Department of Labor. Unemployment Insurance Weekly Claims.2020. https://www.dol.gov/ui/data.pdf. Accessed April 14, 2020.Google Scholar2. Ahmad K, Chen EW, Nazir U, Cotts W, Andrade A, Trivedi AN, Erqou S, Wu WC. Regional variation in the association of poverty and heart failure mortality in the 3135 counties of the United States.J Am Heart Assoc. 2019; 8:e012422. doi: 10.1161/JAHA.119.012422LinkGoogle Scholar3. Yancy CW. COVID-19 and African Americans [published online April 15, 2020].JAMA. doi: 10.1001/jama.2020.6548Google Scholar4. Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, Dixon S, Rade JJ, Tannenbaum M, Chambers J, et al. Reduction in ST-Segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic [published online April 9, 2020].J Am Coll Cardiol. doi: 10.1016/j.jacc.2020.04.011Google Scholar5. Abraham WT, Fiuzat M, Psotka MA, O'Connor CM. Heart failure collaboratory statement on clinical trials in the Landscape of COVID-19 [published online March 27,2020].JACC Heart Fail. doi: 10.1016/j.jchf.2020.03.005Google Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Mihas P, Rosman L, Armbruster T, Walker J, Deyo Z and Gehi A (2023) Assessing a Virtual Education Intervention for Patients With Atrial Fibrillation, Journal of Cardiovascular Nursing, 10.1097/JCN.0000000000000984, 39:1, (E1-E11), Online publication date: 1-Jan-2024. Paizi@Fauzi W, Suhaimi A, Paizi@Fauzi W and Chung T (2023) Development of Efficacy-Enhanced Heart Failure Rehabilitation Patient Education Materials for Health Behavior Change, American Journal of Health Education, 10.1080/19325037.2023.2209751, 54:4, (282-304), Online publication date: 4-Jul-2023. Manemann S, Weston S, Jiang R, Larson N, Roger V, Takahashi P, Chamberlain A, Singh M, St. Sauver J and Bielinski S (2023) Health Care Utilization and Death in Patients With Heart Failure During the COVID-19 Pandemic, Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 10.1016/j.mayocpiqo.2023.04.004, 7:3, (194-202), Online publication date: 1-Jun-2023. Mahalwar G, Kumar A and Kalra A (2023) Virtual Cardiology: Past, Present, Future Directions, and Considerations, Current Cardiovascular Risk Reports, 10.1007/s12170-023-00719-0, 17:6, (117-122), Online publication date: 1-Jun-2023. Moury P, Ochida N, Motiejunaite J, Collart V, Série M, Gervolino S, Mangeas M, Bouvier J, Couadau E, Mebazaa A and Dupont-Rouzeyrol M (2023) Impact of lockdown on cardiovascular disease hospitalizations in a Zero-COVID-19 country, Public Health, 10.1016/j.puhe.2023.01.029, 217, (98-104), Online publication date: 1-Apr-2023. Correale M, Croella F, Leopizzi A, Mazzeo P, Tricarico L, Mallardi A, Fortunato M, Magnesa M, Ceci V, Puteo A, Iacoviello M, Di Biase M and Brunetti N (2021) The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic, Cardiovascular Drugs and Therapy, 10.1007/s10557-021-07217-8, 37:2, (341-351), Online publication date: 1-Apr-2023. Palazzuoli A, Metra M, Collins S, Adamo M, Ambrosy A, Antohi L, Ben Gal T, Farmakis D, Gustafsson F, Hill L, Lopatin Y, Tramonte F, Lyon A, Masip J, Miro O, Moura B, Mullens W, Radu R, Abdelhamid M, Anker S and Chioncel O (2022) Heart failure during the COVID‐19 pandemic: clinical, diagnostic, management, and organizational dilemmas, ESC Heart Failure, 10.1002/ehf2.14118, 9:6, (3713-3736), Online publication date: 1-Dec-2022. Gori M, Bonmassari R, Correale M, Franzini J, Iacoviello M, Dico G, Moretti M, Navazio A, Pellegrini L, Volpe M and Senni M (2022) LEAP Virtual Visit Assessment (VIVA): a structured protocol for virtual visits for patients with heart failure, Journal of Cardiovascular Medicine, 10.2459/JCM.0000000000001350, 23:10, (685-690), Online publication date: 1-Oct-2022. Cross L, Koren A, Dowling J and Gonzales J (2022) The Impact of COVID-19 on Family Caregivers of Individuals With End-Stage Heart Failure, Journal of Hospice & Palliative Nursing, 10.1097/NJH.0000000000000881, 24:5, (249-257), Online publication date: 1-Oct-2022. Maulana S, Trisyani Y, Mirwanti R, Amirah S, Kohar K, Priyatmoko Putri A and Novianti E (2022) The Potential of Cardiac Telerehabilitation as Delivery Rehabilitation Care Model in Heart Failure during COVID-19 and Transmissible Disease Outbreak: A Systematic Scoping Review of the Latest RCTs, Medicina, 10.3390/medicina58101321, 58:10, (1321) Li C, Marton I, Harari D, Shemesh M, Kalchenko V, Pardo M, Schreiber G and Rudich Y (2022) Gelatin Stabilizes Nebulized Proteins in Pulmonary Drug Delivery against COVID-19, ACS Biomaterials Science & Engineering, 10.1021/acsbiomaterials.2c00419, 8:6, (2553-2563), Online publication date: 13-Jun-2022. Hammond M, Everitt I and Khan S (2022) New strategies and therapies for the prevention of heart failure in high‐risk patients, Clinical Cardiology, 10.1002/clc.23839, 45:S1, Online publication date: 1-Jun-2022. Severino P, D'Amato A, Prosperi S, Magnocavallo M, Maraone A, Notari C, Papisca I, Mancone M and Fedele F (2022) Clinical Support through Telemedicine in Heart Failure Outpatients during the COVID-19 Pandemic Period: Results of a 12-Months Follow Up, Journal of Clinical Medicine, 10.3390/jcm11102790, 11:10, (2790) Álvarez-Martín C, Ribera A, Marsal J, Ariza-Solé A, Pérez-Hoyos S, Oristrell G, Soriano-Colomé T, Romaguera R, Pijoan J, Lidón R, Mauri J and Ferreira-González I (2022) Dynamics of Emergency Cardiovascular Hospital Admissions and In-Hospital Mortality During the COVID-19 Pandemic: Time Series Analysis and Impact of Socioeconomic Factors, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2022.827212, 9 Fifolt M, White-Williams C, Shirey M, Su W and Talley M (2022) The Association of COVID-19 on Organizational Attitudes in Primary Care Among Interprofessional Practice Clinics, Journal of Ambulatory Care Management, 10.1097/JAC.0000000000000411, 45:2, (95-104), Online publication date: 1-Apr-2022. Soares W, Melnick E, Nath B, D'Onofrio G, Paek H, Skains R, Walter L, Casey M, Napoli A, Hoppe J and Jeffery M (2022) Emergency Department Visits for Nonfatal Opioid Overdose During the COVID-19 Pandemic Across Six US Health Care Systems, Annals of Emergency Medicine, 10.1016/j.annemergmed.2021.03.013, 79:2, (158-167), Online publication date: 1-Feb-2022. Morishita T, Takada D, Shin J, Higuchi T, Kunisawa S, Fushimi K and Imanaka Y (2021) Effects of the COVID‐19 pandemic on heart failure hospitalizations in Japan: interrupted time series analysis, ESC Heart Failure, 10.1002/ehf2.13744, 9:1, (31-38), Online publication date: 1-Feb-2022. Bhatt A, Adler E, Albert N, Anyanwu A, Bhadelia N, Cooper L, Correa A, Defilippis E, Joyce E, Sauer A, Solomon S, Vardeny O, Yancy C and Lala A (2022) Coronavirus Disease-2019 and Heart Failure: A Scientific Statement From the Heart Failure Society of America, Journal of Cardiac Failure, 10.1016/j.cardfail.2021.08.013, 28:1, (93-112), Online publication date: 1-Jan-2022. Harrington N, Bui Q, Wei Z, Hernandez-Pacheco B, DeYoung P, Wassell A, Duwaik B, Desai A, Bhatt D, Agnihotri P, Owens R, Coleman T and King K (2021) Passive longitudinal weight and cardiopulmonary monitoring in the home bed, Scientific Reports, 10.1038/s41598-021-03105-1, 11:1 Manemann S, Gerber Y, Bielinski S, Chamberlain A, Margolis K, Weston S, Killian J and Roger V (2021) Recent trends in cardiovascular disease deaths: a state specific perspective, BMC Public Health, 10.1186/s12889-021-11072-5, 21:1, Online publication date: 1-Dec-2021. Donnelly C, Ashcroft R, Bobbette N, Mills C, Mofina A, Tran T, Vader K, Williams A, Gill S and Miller J (2021) Interprofessional primary care during COVID-19: a survey of the provider perspective, BMC Family Practice, 10.1186/s12875-020-01366-9, 22:1, Online publication date: 1-Dec-2021. Adam S, Zahra S, Chor C, Khare Y and Harky A (2020) COVID-19 pandemic and its impact on service provision: A cardiology prospect, Acta Cardiologica, 10.1080/00015385.2020.1787636, 76:8, (830-837), Online publication date: 10-Nov-2021. Radhakrishnan K, Allen C, DeMain A and Park L (2021) Impact of COVID-19 on Heart Failure Self-Care, Journal of Cardiovascular Nursing, 10.1097/JCN.0000000000000794, 36:6, (609-617), Online publication date: 1-Nov-2021. Onohuean H, Al-kuraishy H, Al-Gareeb A, Qusti S, Alshammari E and Batiha G (2021) Covid-19 and development of heart failure: mystery and truth, Naunyn-Schmiedeberg's Archives of Pharmacology, 10.1007/s00210-021-02147-6, 394:10, (2013-2021), Online publication date: 1-Oct-2021. Kulkarni K, Sevakula R, Kassab M, Nichols J, Roberts J, Isselbacher E and Armoundas A (2021) Ambulatory monitoring promises equitable personalized healthcare delivery in underrepresented patients, European Heart Journal - Digital Health, 10.1093/ehjdh/ztab047, 2:3, (494-510), Online publication date: 30-Sep-2021. Ploux S, Strik M, Abu-Alrub S, Ramirez F, Buliard S, Marchand H, Picard F, Eschalier R, Haïssaguerre M and Bordachar P (2021) Remote monitoring of patients with heart failure during the first national lockdown for COVID-19 in France, European Heart Journal - Digital Health, 10.1093/ehjdh/ztab044, 2:3, (487-493), Online publication date: 30-Sep-2021. Mahrokhian S, Liang C, Nordan T, Vest A, Kiernan M, DeNofrio D, Couper G and Kawabori M (2021) The Impact of COVID-19 on Heart Transplantations and Waitlist Additions in the United States, ASAIO Journal, 10.1097/MAT.0000000000001499, 67:7, (721-723), Online publication date: 1-Jul-2021. Adabag S, Zimmerman P, Black A, Madjid M, Safavi‐Naeini P and Cheng A (2021) Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak, Journal of the American Heart Association, 10:11, Online publication date: 1-Jun-2021. Papautsky E, Rice D, Ghoneima H, McKowen A, Anderson N, Wootton A and Veldhuis C (2021) Characterizing Health Care Delays and Interruptions in the United States During the COVID-19 Pandemic: Internet-Based, Cross-sectional Survey Study, Journal of Medical Internet Research, 10.2196/25446, 23:5, (e25446) Rosman L, Armbruster T, Kyazimzade S, Tugaoen Z, Mazzella A, Deyo Z, Walker J, Machineni S and Gehi A (2021) Effect of a virtual self‐management intervention for atrial fibrillation during the outbreak of COVID‐19, Pacing and Clinical Electrophysiology, 10.1111/pace.14188, 44:3, (451-461), Online publication date: 1-Mar-2021. Nan J, Zhang T, Tian Y, Song K, Li Q, Fu Q, Ma Y and Jin Z (2021) Impact of the 2019 Novel Coronavirus Disease Pandemic on the Performance of a Cardiovascular Department in a Non-epidemic Center in Beijing, China, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2021.630816, 8 Charman S, Velicki L, Okwose N, Harwood A, McGregor G, Ristic A, Banerjee P, Seferovic P, MacGowan G and Jakovljevic D (2020) Insights into heart failure hospitalizations, management, and services during and beyond COVID‐19, ESC Heart Failure, 10.1002/ehf2.13061, 8:1, (175-182), Online publication date: 1-Feb-2021. Wand A, Russell S and Gilotra N (2021) Ambulatory Management of Worsening Heart Failure: Current Strategies and Future Directions, Heart International, 10.17925/HI.2021.15.1.49, 15:1, (49), . Khalili H, Lodhi H, Luna M, Hasan R, Banerjee S, Harvey J, Byrne T, Hanzel G, Abbas A, Bhatia N, Shreenivas S, Mathews A, Bansal P, Morcos R and Maini B (2021) Decline in the Volume of Structural Heart Procedures in the United States Due to the COVID-19 Pandemic, Structural Heart, 10.1080/24748706.2020.1836436, 5:1, (97-98), Online publication date: 1-Jan-2021. Bellam N, Denfeld Q, Kamdar F, Alexy T, Breathett K, Patel P, Faulkenberg K, Moyer B, Psotka M and Ginwalla M (2021) Navigating Early Careers in Heart Failure in the Era of Novel Coronavirus Disease-2019, Journal of Cardiac Failure, 10.1016/j.cardfail.2020.11.010, 27:1, (97-99), Online publication date: 1-Jan-2021. Bories M and Abi Akar R (2020) End-stage heart failure patients should be treated instantly despite a pandemic with all-time available technology to ensure best outcomes, European Heart Journal Supplements, 10.1093/eurheartj/suaa183, 22:Supplement_P, (P33-P37), Online publication date: 23-Dec-2020. Bayes-Genis A, Codina P, Abdul-Jawad Altisent O, Santiago E, Domingo M, Cediel G, Spitaleri G and Lupón J (2020) Advanced remote care for heart failure in times of COVID-19 using an implantable pulmonary artery pressure sensor: the new normal, European Heart Journal Supplements, 10.1093/eurheartj/suaa169, 22:Supplement_P, (P29-P32), Online publication date: 23-Dec-2020. Tersalvi G, Winterton D, Cioffi G, Ghidini S, Roberto M, Biasco L, Pedrazzini G, Dauw J, Ameri P and Vicenzi M (2020) Telemedicine in Heart Failure During COVID-19: A Step Into the Future, Frontiers in Cardiovascular Medicine, 10.3389/fcvm.2020.612818, 7 Wagner J and Ambrosy A (2020) Hospitalizations for heart failure and mortality risk during the evolving coronavirus disease 2019 pandemic – the wave may break but a dangerous undertow persists, European Journal of Heart Failure, 10.1002/ejhf.2043, 22:12, (2225-2227), Online publication date: 1-Dec-2020. Severino P, D'Amato A, Saglietto A, D'Ascenzo F, Marini C, Schiavone M, Ghionzoli N, Pirrotta F, Troiano F, Cannillo M, Mennuni M, Rognoni A, Rametta F, Galluzzo A, Agnes G, Infusino F, Pucci M, Lavalle C, Cacciotti L, Mather P, Grosso Marra W, Ugo F, Forleo G, Viecca M, Morici N, Patti G, De Ferrari G, Palazzuoli A, Mancone M and Fedele F (2020) Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak, ESC Heart Failure, 10.1002/ehf2.13043, 7:6, (4182-4188), Online publication date: 1-Dec-2020. Chagué F, Boulin M, Eicher J, Bichat F, Saint Jalmes M, Cransac‐Miet A, Soudry‐Faure A, Danchin N, Cottin Y and Zeller M (2020) Impact of lockdown on patients with congestive heart failure during the coronavirus disease 2019 pandemic, ESC Heart Failure, 10.1002/ehf2.13016, 7:6, (4420-4423), Online publication date: 1-Dec-2020. Lee K, Thomas R, Tan T, Leong T, Steimle A and Go A (2020) The Heart Failure Readmission Intervention by Variable Early Follow-up (THRIVE) Study, Circulation: Cardiovascular Quality and Outcomes, 13:10, (e006553), Online publication date: 1-Oct-2020. Timmis K, Huang W and Timmis J (2020) Strategies to minimize preventable morbidity and mortality resulting from pandemics like COVID ‐19 , Environmental Microbiology, 10.1111/1462-2920.15217, 22:10, (4085-4092), Online publication date: 1-Oct-2020. Lakkireddy D, Chung M, Deering T, Gopinathannair R, Albert C, Epstein L, Harding C, Hurwitz J, Jeffery C, Krahn A, Kusumoto F, Lampert R, Mansour M, Natale A, Patton K, Seiler A, Shah M, Wang P and Russo A (2020) Guidance for rebooting electrophysiology through the COVID-19 pandemic from the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Heart Rhythm, 10.1016/j.hrthm.2020.06.012, 17:9, (e242-e254), Online publication date: 1-Sep-2020. Almufleh A and Givertz M (2020) Virtual Health During a Pandemic, Circulation: Heart Failure, 13:8, Online publication date: 1-Aug-2020. DeFilippis E, Reza N, Donald E, Givertz M, Lindenfeld J and Jessup M (2020) Considerations for Heart Failure Care During the COVID-19 Pandemic, JACC: Heart Failure, 10.1016/j.jchf.2020.05.006, 8:8, (681-691), Online publication date: 1-Aug-2020. Lakkireddy D, Chung M, Deering T, Gopinathannair R, Albert C, Epstein L, Harding C, Hurwitz J, Jeffery C, Krahn A, Kusumoto F, Lampert R, Mansour M, Natale A, Patton K, Seiler A, Shah M, Wang P and Russo A (2020) Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, JACC: Clinical Electrophysiology, 10.1016/j.jacep.2020.06.004, 6:8, (1053-1066), Online publication date: 1-Aug-2020. Ranard L, Fried J, Abdalla M, Anstey D, Givens R, Kumaraiah D, Kodali S, Takeda K, Karmpaliotis D, Rabbani L, Sayer G, Kirtane A, Leon M, Schwartz A, Uriel N and Masoumi A (2020) Approach to Acute Cardiovascular Complications in COVID-19 Infection, Circulation: Heart Failure, 13:7, Online publication date: 1-Jul-2020.Lakkireddy D, Chung M, Deering T, Gopinathannair R, Albert C, Epstein L, Harding C, Hurwitz J, Jeffery C, Krahn A, Kusumoto F, Lampert R, Mansour M, Natale A, Patton K, Seiler A, Shah M, Wang P and Russo A (2020) Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Circulation: Arrhythmia and Electrophysiology, 13:7, Online publication date: 1-Jul-2020. May 2020Vol 13, Issue 5 Advertisement Article InformationMetrics © 2020 American Heart Association, Inc.https://doi.org/10.1161/CIRCHEARTFAILURE.120.007219PMID: 32352841 Originally publishedApril 30, 2020 Keywordscoronavirusclinical trialheart failurepovertysocial isolationtelemedicinePDF download Advertisement SubjectsComplicationsEthics and PolicyHeart FailureQuality and OutcomesRisk Factors
Referência(s)